Sirtuins and NAD+: The Longevity Pathway Explained

The Seven Sirtuins and Where They Work

Sirtuins are not interchangeable. They differ in location, in substrate and in function, and lumping them together as "the longevity genes" loses the useful detail.

• SIRT1. Nucleus and cytoplasm. The most studied. Deacetylates PGC-1 alpha, FOXO transcription factors, p53 and histones, influencing mitochondrial biogenesis, stress resistance and metabolic adaptation.
• SIRT2. Mainly cytoplasmic. Involved in cell cycle regulation and tubulin acetylation.
• SIRT3. Mitochondrial, and arguably as important as SIRT1 for aging biology. Deacetylates a large share of mitochondrial metabolic enzymes, including superoxide dismutase 2, linking it to mitochondrial antioxidant capacity and fatty acid oxidation.
• SIRT4 and SIRT5. Mitochondrial, with roles in amino acid metabolism, urea cycle regulation and desuccinylation rather than classical deacetylation.
• SIRT6. Nucleus. DNA repair, telomere maintenance and genome stability. Overexpression extends lifespan in male mice, and its loss produces a rapid aging phenotype, making it one of the strongest single-gene links to aging in mammals.
• SIRT7. Nucleolus. Ribosome biogenesis and stress response.

Note that SIRT6 has the cleanest mammalian longevity evidence of the family while receiving a small fraction of the commercial attention given to SIRT1.

Why NAD+ Is the Control Variable

Sirtuins are not simply regulated by NAD+; they consume it. Each deacetylation reaction cleaves NAD+, releasing nicotinamide and producing an acetylated ADP-ribose product. This makes sirtuin activity directly dependent on NAD+ availability rather than merely responsive to it.

Two consequences follow. First, sirtuins function as energy state sensors by construction: NAD+ rises when the cell is oxidising rather than storing, which is what happens during fasting and exercise, and sirtuin activity rises with it. Second, nicotinamide, the reaction product, inhibits sirtuins, which is a classic product feedback arrangement and the reason high-dose nicotinamide supplementation is a questionable route to sirtuin activation.

NAD+ availability declines with age in multiple tissues, driven more by increased consumption than by reduced synthesis. CD38 activity rises with inflammatory signalling, PARP activity rises with accumulated DNA damage, and both compete with sirtuins for the same limited pool. This competition is the mechanistic reason inflammatory load and DNA damage reduce sirtuin-mediated maintenance, and it is a better argument for reducing inflammatory load than for buying precursors.

The Replication Controversy and What It Settled

The sirtuin field has had two significant corrections, and both are instructive about how longevity claims should be read.

Invertebrate lifespan. Early reports that sirtuin overexpression extends lifespan in worms and flies were influential. Later work found that the original results were substantially attributable to genetic background differences rather than to sirtuin expression; when the comparisons were properly controlled, the lifespan effects largely disappeared or shrank considerably. This does not mean sirtuins are irrelevant, but it removed the foundational claim that they are a conserved longevity switch.

Direct activation by small molecules. The report that resveratrol directly activates SIRT1 was found to depend on a fluorophore attached to the assay substrate. With native substrates, direct activation was not reproduced. The current understanding is that resveratrol and similar compounds affect sirtuin activity indirectly, largely by raising NAD+ availability through AMPK activation.

What survived. Sirtuins do mediate part of the caloric restriction response in mammals. SIRT6 overexpression does extend lifespan in mice and its loss produces accelerated aging. SIRT3 does regulate a large share of mitochondrial metabolism. NAD+ availability does decline with age and does constrain sirtuin activity. The core biology is sound; the simple narrative built on top of it was not.

What This Means for Supplementation

Three approaches to raising sirtuin activity exist commercially, with different levels of support.

Raising NAD+ with precursors. NR and NMN reliably raise blood NAD+ in humans. Whether that raises tissue NAD+ where it matters is less clear, since several trials found no increase in muscle NAD+ despite large increases in blood. And whether raised NAD+ translates into meaningful sirtuin-mediated benefit in a healthy adult has not been demonstrated.

Direct activators. The original premise has not survived scrutiny. Compounds marketed as sirtuin activators generally act, if at all, through AMPK and NAD+ rather than on the enzyme directly.

Reducing NAD+ consumption. The least commercially interesting and most mechanistically defensible. Lowering inflammatory load reduces CD38-driven consumption. Reducing DNA damage exposure, including ultraviolet radiation and tobacco smoke, reduces PARP-driven consumption. Exercise increases NAMPT expression in muscle, raising synthesis capacity locally. None of these can be sold in a bottle, which is a reasonable explanation for their relative absence from the conversation.

The Non-Supplement Levers

The interventions that most reliably increase sirtuin activity are the ones that create the energy state sirtuins evolved to sense.

• Fasting and caloric restriction. Raise the NAD+ to NADH ratio and activate sirtuin signalling. This is the state the system was built to detect.
• Exercise. Increases NAMPT expression, raises NAD+ turnover, and activates AMPK, which converges on the same downstream targets including PGC-1 alpha.
• Circadian alignment. NAMPT expression is under circadian control, and sirtuin activity oscillates over the day. Sleep disruption and irregular eating windows flatten that oscillation.
• Reduced inflammatory load. Directly reduces competition for the NAD+ pool.

A person doing none of these while spending significantly on NAD+ precursors is attempting to fill a bucket with a hole in it.

An Honest Summary

Sirtuins are real, important and considerably less simple than their popular framing. They connect the cell's energy state to gene expression and mitochondrial function, they participate in the caloric restriction response, and at least one family member has strong mammalian longevity evidence.

What the field does not support is the proposition that a supplement activating sirtuins produces measurable longevity benefit in humans. The direct-activation premise did not replicate. The precursor approach raises a biomarker whose functional consequences in healthy adults remain unproven. The mechanistic story is coherent enough to justify continued research and not strong enough to justify confident recommendation.

The reasonable position is to read sirtuin biology as a good explanation for why fasting, exercise and circadian regularity work, rather than as a target to be hit pharmacologically.